renal cell carcinoma

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Proleukin Market Set to Expand 6.1% Annually Through 2030 Amid Cancer, CF Growth

Proleukin market projected to grow 6.1% annually to $1.68M by 2030, driven by rising cancer prevalence and expanded indications. Iovance Biotherapeutics strengthens position via 2023 acquisition.
NVSIOVAcancer treatmentcystic fibrosis